"Within the X-TOLE open-label extension study, we are seeing patients - some who have been on azetukalner for more ... or equivalent, in 2025. IND-enabling work is underway with multiple Kv7 ...
Just before midnight on July 19, 1952, a Washington National Airport air traffic controller spotted seven unusual objects on radar—first hovering about 15 miles south-southwest of the city, later ...
The study, published in Eye, found that the treatment was safe and effective in preventing ... Lead researcher, Professor Paul Gissen (UCL Great Ormond Street Institute of Child Health and GOSH) said: ...
Mereo BioPharma Group plc (NASDAQ: MREO) ("Mereo” or the "Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced its financial results for the third quarter ...